Difference between revisions of "Wilms tumor"
Jump to navigation
Jump to search
Line 74: | Line 74: | ||
# '''SIOP 93-01:''' de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, Tournade MF; SIOP. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet. 2004 Oct 2-8;364(9441):1229-35. [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)17139-0/fulltext link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/15464183 PubMed] | # '''SIOP 93-01:''' de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, Tournade MF; SIOP. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet. 2004 Oct 2-8;364(9441):1229-35. [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(04)17139-0/fulltext link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/15464183 PubMed] | ||
# '''SIOP WT 2001:''' Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015 Sep 19;386(9999):1156-64. Epub 2015 Jul 9. [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62395-3/fulltext link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/26164096 PubMed] | # '''SIOP WT 2001:''' Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015 Sep 19;386(9999):1156-64. Epub 2015 Jul 9. [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62395-3/fulltext link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/26164096 PubMed] | ||
+ | |||
+ | ==Vincristine monotherapy {{#subobject:ec500f|Regimen=1}}== | ||
+ | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
+ | |- | ||
+ | |[[#top|back to top]] | ||
+ | |} | ||
+ | ===Regimen {{#subobject:a67321|Variant=1}}=== | ||
+ | {| class="wikitable" style="width: 100%; text-align:center;" | ||
+ | !style="width: 50%"|Study | ||
+ | !style="width: 50%"|[[Levels_of_Evidence#Evidence|Evidence]] | ||
+ | |- | ||
+ | |[https://jamanetwork.com/journals/jama/article-abstract/335953 Sullivan et al. 1967] | ||
+ | | style="background-color:#ffffbe" |Pilot | ||
+ | |- | ||
+ | |} | ||
+ | ====Chemotherapy==== | ||
+ | *[[Vincristine (Oncovin)]] | ||
+ | ====Subsequent treatment==== | ||
+ | *[[Surgery#Surgical_resection|Surgical resection]] | ||
+ | ===References=== | ||
+ | # Sullivan MP, Sutow WW, Cangir A, Taylor G. Vincristine sulfate in management of Wilms' tumor: replacement of preoperative irradiation by chemotherapy. JAMA. 1967 Oct 30;202(5):381-4. [https://jamanetwork.com/journals/jama/article-abstract/335953 link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/4293363 PubMed] | ||
[[Category:Wilms' tumor regimens]] | [[Category:Wilms' tumor regimens]] | ||
[[Category:Disease-specific pages]] | [[Category:Disease-specific pages]] | ||
[[Category:Pediatric cancers]] | [[Category:Pediatric cancers]] |
Revision as of 03:41, 1 January 2019
Section editor | |
---|---|
Wayne H. Liang, MD, MS Birmingham, AL Twitter: WayneLiangMD |
3 regimens on this page
3 variants on this page
|
All lines of therapy
Dactinomycin monotherapy
back to top |
Regimen
Study | Evidence | Comparator | Efficacy |
---|---|---|---|
Wolff et al. 1968 | Randomized (E) | Single course of dactinomycin | Seems to have superior RFS |
Preceding treatment
Chemotherapy
- Dactinomycin (Cosmegen) 15 mcg/kg IV once per day on days 1 to 5
6-week cycle for 3 cycles, then 3-month cycle for 4 cycles
References
- Wolff JA, Newton WA Jr, Krivit W, D'Angio GJ. Single versus multiple dose dactinomycin therapy of Wilms's tumor: a controlled co-operative study conducted by the Children's Cancer Study Group A (formerly Acute Leukemia Co-operative Chemotherapy Group A). N Engl J Med. 1968 Aug 8;279(6):290-4. link to original article PubMed
- Update: Wolff JA, D'Angio G, Hartmann J, Krivit W, Newton WA Jr. Long-term evaluation of single versus multiple courses of actinomycin D therapy of Wilms's tumor. N Engl J Med. 1974 Jan 10;290(2):84-6. link to original article contains verified protocol PubMed
Dactinomycin & Vincristine
back to top |
Regimen
Study | Evidence | Comparator | Efficacy |
---|---|---|---|
de Kraker et al. 2004 (SIOP 93-01) | Phase III (E) | Prolonged chemotherapy | Equivalent EFS |
Pritchard-Jones et al. 2015 (SIOP WT 2001) | Phase III (E) | Dactinomycin, Doxorubicin, Vincristine | Non-inferior EFS |
Preceding treatment
Chemotherapy
References
- SIOP 93-01: de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, Tournade MF; SIOP. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet. 2004 Oct 2-8;364(9441):1229-35. link to original article PubMed
- SIOP WT 2001: Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015 Sep 19;386(9999):1156-64. Epub 2015 Jul 9. link to original article PubMed
Vincristine monotherapy
back to top |
Regimen
Study | Evidence |
---|---|
Sullivan et al. 1967 | Pilot |
Chemotherapy
Subsequent treatment
References
- Sullivan MP, Sutow WW, Cangir A, Taylor G. Vincristine sulfate in management of Wilms' tumor: replacement of preoperative irradiation by chemotherapy. JAMA. 1967 Oct 30;202(5):381-4. link to original article PubMed